Transplantation tolerance: A complex scenario awaiting clinical applicability

Contributions to Nephrology

Volumn 146, Issue , 2005, Pages 95-104

  Sayegh, Mohamed H ^a   Perico, Norberto ^b,c   Remuzzi, Giuseppe ^b,d  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b OSPEDALI RIUNITI   (Italy)

^c Center for Research on Organ Transplant 'Chiara Cucchi de Alessandri and Gilberto Crespi'   (Italy)

^d MARIO NEGRI INSTITUTE FOR PHARMACOLOGICAL RESEARCH   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOSUPPRESSIVE AGENT;

ANIMAL; COMPARATIVE STUDY; DISEASE MODEL; DRUG EFFECT; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HISTOCOMPATIBILITY; HUMAN; IMMUNOLOGY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY TRANSPLANTATION; LYMPHOCYTE DEPLETION; MALE; METHODOLOGY; PHYSIOLOGY; PROGNOSIS; REVIEW; RISK ASSESSMENT; T LYMPHOCYTE; TRANSPLANTATION TOLERANCE;

ANIMALS; DISEASE MODELS, ANIMAL; FEMALE; GRAFT REJECTION; GRAFT SURVIVAL; HUMANS; IMMUNOSUPPRESSION; IMMUNOSUPPRESSIVE AGENTS; KIDNEY TRANSPLANTATION; LYMPHOCYTE DEPLETION; MALE; PROGNOSIS; RISK ASSESSMENT; T-LYMPHOCYTES; TRANSPLANTATION IMMUNOLOGY; TRANSPLANTATION TOLERANCE;

EID: 16544377051     PISSN: 03025144     EISSN: None     Source Type: Book Series    
DOI: None     Document Type: Review

References (44)

1. Hariharan S, Johnson CP, Bresnahan BA, Taranto SE, McIntosh MJ, Stablein D: Improved graft survival after renal transplantation in the United States, 1988 to 1996. N Engl J Med 2000;342:605-612.
2. Meier-Kriesche H-U, Schold JD, Srinivas TR, Kaplan B: Lack of improvement in renal allograft survival despite a marked decrease in acute rejection rates over the most recent era. Am J Transplant 2004;4:378-383.
3. Denton MD, Magee CC, Sayegh MH: Immunosuppressive strategies in transplantation. Lancet 1999;353:1083-1091.
4. Kramer BK, Zulke C, Kammerl MC, Schmidt C, Hengstenberg C, Fischereder M, Merienhagen J, European Tacrolimus vs. Cyclosporine Microemulsion Transplantation Study Group: Cardiovascular risk factors and estimated risk of CAD in a randomized trial comparing calcineurin inhibitors in renal transplantation. Am J Transplant 2003;3:982-987.
5. Womer KL, Vella JP, Sayegh MH: Chronic allograft dysfunction: Mechanism and new approaches to therapy. Semin Nephrol 2000;20:126-147.
6. Billingham RE, Brent L, Medawar PB: Actively acquired tolerance of foreign cells. Nature 1953;172:603-606.
7. Salama AD, Remuzzi G, Harmon WE, Sayegh MH: Challenges to achieving clinical transplantation tolerance. J Clin Invest 2001;108:943-948.
8. Sayegh MH, Turka LA: The role of T-cell costimulatory activation pathways in transplant rejection. N Engl J Med 1998;338:1813-1821.
9. Dong VM, Wormer KL, Sayegh MH: Transplantation tolerance: The concept and its applicability. Pediatr Transplant 1999;3:181-192.
10. Wekerle T, Blaha P, Koporc Z, Bigenzahn S, Pusch M, Muehlbacher F: Mechanism of tolerance induction through the transplantation of donor hematopoietic stem cells: Central versus peripheral tolerance. Transplantation 2003;75:S21-S25.
11. Zheng XX, Sanchez-Fueyo A, Domenig C, Storm TB: The balance of deletion and regulation in allograft tolerance. Immunol Rev 2003;196:75-84.
12. Starzl TE, Demetris AJ, Murase N, Ildstad S, Ricordi C, Trucco M: Cell migration, chimerism, and graft acceptance. Lancet 1992;339:1579-1582.
13. Manilay LO, Pearson DA, Sergio JJ, Swenson KG, Sykes M: Intrathymic deletion of alloreactive T cells in mixed bone marrow chimeras prepared with a nonmyeloablative conditioning regimen. Transplantation 1998;66:96-102.
14. Tomita Y, Kahan A, Sykes M: Role of intrathymic clonal deletion and peripheral anergy in transplantation tolerance induced by bone marrow transplantation in mice conditioned with a non-myeloablative regimen. J Immunol 1994;153:1807-1804.
15. Noris M, Cugini D, Casiraghi F, Azzollini N, De Deus Viera Moraes L, Mister M, Pezzotta A, Cavinato RA, Aiello S, Perico N, Remuzzi G: Thymic microchimerism correlates with the outcome of tolerance-inducing protocols for solid organ transplantation. J Am Soc Nephrol 2001;12:2015-2826.
16. Wekerle T, Kurtz J, Ito H, Ronquillo JV, Dong V, Zhao G, Shaffer J, Sayegh MH, Sykes M: Allogeneic bone marrow transplantation with co-stimulatory blockade induces macrochimerism and tolerance without cytoreductive host treatment. Nat Med 2000;6:464-469.
17. Wekerle T, Sayegh MH, Hill J, Zhao Y, Chandraker A, Zhao G, Sykes M: Extrathymic T cell deletion and allogeneic stem cell engraftment induced with co-stimulatory blockade is followed by central T cell tolerance. J Exp Med 1998;187:2037-2044.
18. Schwartz RH: A cell culture model for T lymphocyte clonal anergy. Science 1990;248:1349-1356.
19. Chen W, Issazadeh S, Sayegh MH, Khoury SJ: In vivo mechanism of acquired thymic tolerance. Cell Immunol 1997;179:165-173.
20. Chen T-C, Cobbold SP, Fairchild PJ, Waldmann H: Generation of anergic and regulatory T cells following prolonged exposure to a harmless antigen. J Immunol 2004;172:5900-5907.
21. Vermeiren J, Ceuppens JL, Van Ghelue M, Witters P, Bullens D, Mages HW, Kroczek RA, Van Gool SW: Human T cell activation by costimulatory signal-deficient allogeneic cells induces inducible costimulator-expressing anergic T cells with regulatory cell activity. J Immunol 2004;172:5371-5378.
22. Waldmann H, Qin S, Cobbold S: Monoclonal antibodies as agents to reinduce tolerance in autoimmunity. J Autoimmun 1992;5(suppl A):93.
23. Wood KJ, Sakaguchi S: Regulatory T cells in transplantation tolerance. Nat Rev Immunol 2003;3:199-210.
24. Sykes M: Mixed chimerism and transplant tolerance. Immunity 2001;14:417-424.
25. Thomson AW, Lu L: Dendritic cells as regulators of immune reactivity: Implications for transplantation. Transplantation 1999;68:1-8.
26. Zavazava N: Embryonic stem cells and potency to induce transplantation tolerance. Expert Opin Biol Ther 2003;3:5-13.
27. Tomasoni S, Azzollini N, Casiraghi F, Capogrossi MC, Remuzzi G, Benigni A: CTLA4Ig gene transfer prolongs survival and induces donor-specific tolerance in a rat renal allograft. J Am Soc Nephrol 2000;11:747-752.
28. Kirk AD: Transplantation tolerance: A look at the nonhuman primate literature in the light of modern tolerance theories. Crit Rev Immunol 1999;19:349-388.
29. Watts TH, DeBenedette MA: T cell co-stimulatory molecules other than CD28. Curr Opin Immunol 2000;10:57-62.
30. Li XC, Strom TB, Turka LA, Wells AD: T cell death and transplantation tolerance. Immunity 2001;14:407-416.
31. Burlingham WJ, Grailer AP, Fechner JH Jr, Kusaka S, Trucco M, Kocova M, Belzer FO, Sollinger HW: Microchimerism linked to cytotoxic T lymphocyte functional unresponsiveness (clonal anergy) in a tolerant renal transplant recipient. Transplantation 1995;59:1147-1155.
32. Strober S, Benike C, Krishnaswamy S, Engelman EG, Grumet FC: Clinical transplantation tolerance twelve years after prospective withdrawal of immunosuppressive drugs: Studies of chimerism and anti-donor reactivity. Transplantation 2000;69:1549-1554.
33. Strober S, Dhillon M, Schubert M, Holm B, Engelman EG, Benike C, Hoppe R, Sibley R, Myburgh JA, Collins G: Acquired immune tolerance to cadaveric renal allografts. A study of three patients treated with total lymphoid irradiation. N Engl J Med 1989;321:28-33.
34. Sayegh MH, Fine NA, Smith JL, Rennke HG, Milford EL, Tilney NL: Immunologic tolerance to renal allografts after bone marrow transplants from the same donors. Ann Intern Med 1991;114:954-955.
35. Spitzer TR, Delmonico F, Tolkoff-Rubin N, McAfee S, Sackstein R, Saidman S, Colby C, Sachs DH, Cosimi AB: Combined histocompatibility leukocyte antigen matched donor bone marrow and renal transplantation for multiple myeloma and end stage renal disease: The induction of allograft tolerance through mixed lymphohematopoietic chimerism. Transplantation 1999;68:480-484.
36. Buhler LH, Spitzer TR, Sykes M, Sachs DH, Delmonico F, Tolkoff-Rubin N, Saidman SL, Sackstein R, McAfee S, Dey B, Colby C, Cosimi AB: Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease. Transplantation 2002;74:1405-1409.
37. Ciancio G, Miller J, Garcia-Morales RO, Carreno M, Burke GW 3rd, Roth D, Kupin W, Tzakis AG, Ricordi C, Rosen A, Fuller L, Esquenazi V: Six-year clinical effect of donor bone marrow infusion in renal transplant patients. Transplantation 2001;71:827-835.
38. Millan MT, Shizuru JA, Hoffmann P, Dejbakhsh-Jones S, Scandling JD, Grumet FC, Tan JC, Salvatierra O, Hoppe RT, Strober S: Mixed chimerism and immunosuppressive drug withdrawal after HLA-mismatched kidney and hematopoietic progenitor transplantation. Transplantation 2002;73:1386-1391.
39. Strom TB, Suthanthiran M: Prospects and applicability of molecular diagnosis of allograft rejection. Semin Nephrol 2000;20:103-107.
40. Li Y, Li XC, Zheng XX, Wells AD, Turka L, Strom TB: Blocking both signal 1 and signal 2 of T-cell activation prevents apoptosis of alloreactive T cells and induction of peripheral allograft tolerance. Nat Med 1999;5:1298-1302.
41. Sho M, Sandner SE, Najafian N, Salama AD, Dong V, Yamada A, Kishimoto K, Harada H, Schmitt I, Sayegh MH: New insights into the interactions between T-cell costimulatory blockade and conventional immunosuppressive drugs. Ann Surg 2002;236:667-675.
42. Turgeon NA, Iwakoshi NN, Phillips NE, Meyers WC, Welsh RM, Greiner DL, Mordes JP, Rossini AA: Viral infection abrogates CD8(+) T-cell deletion induced by costimulation blockade. J Surg Res 2000;93:63-69.
43. Adams AB, Williams MA, Jones TR, Shirasugi N, Durham MM, Kaech SM, Wherry EJ, Onami T, Lanier JG, Kokko KE, Pearson TC, Ahmed R, Larsen CP: Heterologous immunity provides a potent barrier to transplantation tolerance. J Clin Invest 2003;111:1887-1895.
44. Matthews JB, Ramos E, Bluestone JA: Clinical trials of transplant tolerance: Slow but steady progress. Am J Transplant 2003;3:794-803.